CRED Successfully Navigating European GMO Regulations

CRED Successfully Navigating European GMO Regulations
Learn to navigate the EU GMO legislative framework and implementation for successful clinical trial submissions. The course will will also discuss Canadian requirements. This online course includes presentations that can be accessed on demand and a live question-and-answer panel session and case study presentation.

: 23 April 2020 (live session online); on-demand presentations available for download from 23 March
Where: Online
Time: Live session will take place from 09:30 to 12:30 BST (GMT +1) on 23 April.

Course overview

This course will cover:

  • An introduction and overview of the pharmaceutical GMO environment including the use of GMOs in clinical trials
  • Common pitfalls of GMO submissions from an industry perspective
  • Risk assessments for clinical trials involving GMOs
  • Beyond Europe: feedback from Canada - what you need to know about GMO submissions in Canada
  • Live question and answer session with the speakers
  • Case study on the strategic considerations for clinical trial and GMO submissions 

Benefits to delegates

  • Understand the key issues in biotechnology/biopharmaceuticals and successfully navigate the GMO legislative framework in Europe
  • Be able to advise on GMO submissions within your company or team
  • Gain an appreciation of the requirements for a biotechnology IMPD and be able to complete Regulatory GMO application forms
  • Learn from experts in the field
  • Learn by doing - participate in case studies 
  • Develop skills to increase performance and support career progression 

This course provides 8 CPD hours upon successful completion

To learn more about why Continuing Professional Development is important, visit our Lifelong Learning page.


Download a copy of the programme here.



Jayne HuntJayne Hunt
Associate Director, Regulatory Affairs
Boyd Consultants, UK 
Sabine RuhleSabine Rühle
Senior Associate, Regulatory Affairs
Boyd Consultants, UK 
Janneke Westra-de Vlieger
Associate Director, Regulatory Affairs
Janssen Vaccines & Prevention B.V., the Netherlands 
Myra WidjojoatmodjoMyra Widjojoatmodjo
Director, Global Regulatory Affairs
Janssen Vaccines & Prevention B.V., the Netherlands 

Additional working party members:

  • Carol McConnell, Regulatory Director, Orchard Therapeutics, UK
  • Kathryn Parsley, Associate Director, Regulatory Affairs, Boyd Consultants, UK
  • Pierre Omnes, Executive Director, Site Start-up & Regulatory, Syneos Health, France
  • Sean Russell, Director, Regulatory Affairs, Achilles Therapeutics Ltd, UK


Type Member Non-member 
Standard    £550 + VAT  £675 + VAT

Discounted places
A limited number of discounted places are available at the rates below. Please email us at for a discount code before making your booking.

Those working for regulatory agencies, government agencies or academic institutions 
 £412.50 + VAT
 £506.25 + VAT
Those working for charities, patient groups or in full-time education
 £275 + VAT  £337.50 + VAT

*VAT, if applicable, is charged at the rate of 20%

Terms and conditions

By booking a place on this course you are agreeing to the training terms and conditions


Simply log in or create an account and then register using the 'Register Myself' button that will appear below when you are logged in. 


Your company name
Your VAT country
Your VAT number
Important instructions before booking - If your company name or VAT number does not appear here or you would like to be invoiced using a different VAT number, please email

Register now